When Can We Trust Real‐World Data To Evaluate New Medical Treatments?-Reference-Cited by-同舟云学术

When Can We Trust Real‐World Data To Evaluate New Medical Treatments?

Author:

Simon Gregory E.¹,Bindman Andrew B.²,Dreyer Nancy A.³,Platt Richard⁴,Watanabe Jonathan H.⁵,Horberg Michael⁶,Hernandez Adrian⁷,Califf Robert M.⁸

Affiliation:

1. Kaiser Permanente Washington Health Research Institute Seattle Washington USA

2. Kaiser Foundation Health Plan and Hospitals Redwood City California USA

3. IQVIA Real World Solutions Durham North Carolina USA

4. Harvard Pilgrim Health Care Institute and Harvard Medical School Hartford Connecticut USA

5. University of California Irvine School of Pharmacy and Pharmaceutical Sciences Irvine California USA

6. Kaiser Permanente Mid‐Atlantic Permanente Research Institute and Mid‐Atlantic Permanente Medical Group Rockville Maryland USA

7. Duke Clinical Research Institute Durham North Carolina USA

8. Verily Life Sciences and Google Health South San Francisco California USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

Reference23 articles.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献